MDT - Medtronic plc
NYSE
->
Healthcare
->
Medical Devices
Dublin,
Ireland
Type: Equity
MDT price evolution
MDT
| (in millions $) | 25 Nov 2024 | 26 Aug 2024 | 26 May 2024 | 26 Feb 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1311 | $1284 | ||
| Short term investments | $6532 | $6721 | ||
| Net receivables | $6260 | $6011 | $6128 | $5968 |
| Inventory | $5479 | $5414 | $5217 | $5726 |
| Total current assets | $22438 | $21947 | $21935 | $22513 |
| Long term investments | ||||
| Property, plant & equipment | $6438 | $6282 | $6131 | $5838 |
| Goodwill & intangible assets | $53903 | $54211 | ||
| Total noncurrent assets | $67802 | $68046 | ||
| Total investments | $6532 | $6721 | ||
| Total assets | $90042 | $89749 | $89981 | $90836 |
| Current liabilities | ||||
| Accounts payable | $2376 | $2291 | $2410 | $1992 |
| Deferred revenue | ||||
| Short long term debt | $1553 | $1092 | ||
| Total current liabilities | $12195 | $10287 | $10789 | $9793 |
| Long term debt | $24607 | $26312 | $23932 | $24153 |
| Total noncurrent liabilities | $31302 | $28772 | ||
| Total debt | $27865 | $25024 | ||
| Total liabilities | $41548 | $41802 | $39767 | $39044 |
| Shareholders' equity | ||||
| Retained earnings | $30919 | $30547 | $30403 | $30661 |
| Other shareholder equity | -$3148.13 | -$3274.13 | -$3318.13 | -$3458.13 |
| Total shareholder equity | $47947 | $50214 | ||
| (in millions $) | 31 Dec 2024 | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1284 | $1543 | $3714 | $3593 |
| Short term investments | $6721 | $6416 | $6859 | $7224 |
| Net receivables | $6128 | $5998 | $5551 | $5462 |
| Inventory | $5217 | $5293 | $4616 | $4313 |
| Total current assets | $21935 | $21675 | $23059 | $22548 |
| Long term investments | ||||
| Property, plant & equipment | $6131 | $5569 | $5413 | $5221 |
| Goodwill & intangible assets | $54211 | $56269 | $56097 | $59701 |
| Total noncurrent assets | $68046 | $69273 | $67922 | $70535 |
| Total investments | $6721 | $6416 | $6859 | $7224 |
| Total assets | $89981 | $90948 | $90981 | $93083 |
| Current liabilities | ||||
| Accounts payable | $2410 | $2662 | $2276 | $2106 |
| Deferred revenue | ||||
| Short long term debt | $1092 | $20 | $3742 | $11 |
| Total current liabilities | $10789 | $9051 | $12394 | $8509 |
| Long term debt | $23932 | $24344 | $20372 | $26378 |
| Total noncurrent liabilities | $28772 | $30232 | $25866 | $32972 |
| Total debt | $25024 | $24364 | $24114 | $26389 |
| Total liabilities | $39561 | $39283 | $38260 | $41481 |
| Shareholders' equity | ||||
| Retained earnings | $30403 | $30392 | $30250 | $28594 |
| Other shareholder equity | -$3318 | -$3499 | -$2265 | -$3485 |
| Total shareholder equity | $50214 | $51483 | $52551 | $51428 |
| (in millions $) | 30 Jul 2025 | 25 Nov 2024 | 26 Aug 2024 | 26 May 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $8403 | $7915 | $8589 | |
| Cost of revenue | ||||
| Gross Profit | $5468 | $5163 | $5654 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $3826 | $3743 | $3762 | |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $281 | $220 | $197 | |
| Interest expense | -$72 | -$21 | -$202 | |
| Net income | ||||
| Net income | $1270 | $1042 | $654 | |
| Income (for common shares) | ||||
| (in millions $) | 31 Dec 2024 | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $32364 | $31686 | $30117 | |
| Cost of revenue | $11216 | $10145 | $10483 | |
| Gross Profit | $21148 | $21541 | $19634 | |
| Operating activities | ||||
| Research & development | $2735 | $2746 | $2493 | |
| Selling, general & administrative | $10736 | $10292 | $10148 | |
| Total operating expenses | $16003 | $15788 | $15150 | |
| Operating income | $5145 | $5753 | $4484 | |
| Income from continuing operations | ||||
| EBIT | $5528 | $6048 | $4796 | |
| Income tax expense | $1133 | $456 | $265 | |
| Interest expense | $719 | $553 | $925 | |
| Net income | ||||
| Net income | $3676 | $5039 | $3606 | |
| Income (for common shares) | $3676 | $5039 | $3606 | |
| (in millions $) | 25 Nov 2024 | 26 Aug 2024 | 26 May 2024 | 26 Feb 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$604 | -$259 | -$2366 | -$1670 |
| Financing activities | ||||
| Dividends paid | -$1795 | -$898 | -$3666 | -$2753 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$1265 | -$731 | -$4450 | -$2091 |
| Effect of exchange rate | $35 | $31 | -$230 | -$170 |
| Change in cash and equivalents | $110 | $27 | -$259 | $80 |
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | $3676 | $3758 | $5039 | $3606 |
| Operating activities | ||||
| Depreciation | $2647 | $2697 | $2707 | $2702 |
| Business acquisitions & disposals | -$211 | -$1867 | -$91 | -$994 |
| Stock-based compensation | $393 | $355 | $359 | $344 |
| Total cash flows from operations | $6787 | $6039 | $7346 | $6240 |
| Investing activities | ||||
| Capital expenditures | -$1587 | -$1459 | -$1368 | -$1355 |
| Investments | -$307 | -$171 | -$190 | -$463 |
| Total cash flows from investing | -$2366 | -$3493 | -$1659 | -$2866 |
| Financing activities | ||||
| Dividends paid | -$3666 | -$3616 | -$3383 | -$3120 |
| Sale and purchase of stock | -$1854 | -$337 | -$2115 | -$178 |
| Net borrowings | $1073 | -$598 | -$1 | -$570 |
| Total cash flows from financing | -$4450 | -$4960 | -$5336 | -$4136 |
| Effect of exchange rate | -$230 | $243 | -$231 | $215 |
| Change in cash and equivalents | -$259 | -$2171 | $121 | -$547 |
News
Fundamentals
| Market cap | $119.03B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 1.28B |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.79 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.84 |
| Quick ratio | 1.39 |